A separate license will be required to sell medicines in bulk, according to a new proposal.
- bySherya
- 20 Nov, 2026
The central government has proposed a separate license for the wholesale sale of bulk drugs. Learn about the new forms, licensing rules, monitoring of NDPS drugs, and the relief available to existing license holders.

New rules for drug licenses
To increase oversight of drug wholesale sales and ensure more secure drug supply, the Union Health Ministry has proposed a new proposal. Under this proposal, companies and traders selling bulk drugs will now have to obtain separate licenses. Currently, a single license is granted for the wholesale sale of both bulk drugs and finished medicines.
What is meant by bulk drugs?
The Ministry of Health has issued a draft notification amending the Drugs Rules, 1945. It proposes the creation of separate application forms, Form 19 BC, and license forms, Form 20 BC, for the sale of bulk drugs. Bulk drugs refer to raw pharmaceutical materials used in the manufacture of medicines, including both active and inactive ingredients. The Ministry states that implementing a separate licensing system will enable better monitoring of the purchase and sale of bulk drugs, and will also ensure that a specific wholesaler is dealing in a specific type of drugs.
What are the rules in the new proposal?
Under the new proposal, licenses will require the wholesaler to provide information about all bulk drugs they deal in. This will include drugs covered under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. These drugs will have to be sold under the personal supervision of a qualified and responsible person. A major objective of this change is to strengthen control over antimicrobial resistance (AMR), i.e., the decline in effectiveness of drugs, especially antibiotics. Furthermore, monitoring of the movement and sale of drugs covered under the NDPS will also be increased. This proposal has been approved by the 67th meeting of the Drugs Consultative Committee and the 93rd meeting of the Drugs Technical Advisory Board.
Those with old licenses will get relief.
The Ministry has clarified that existing license holders will not be required to obtain a new license immediately upon the implementation of the new regulations. They will be given sufficient time to adapt to the new rules. The new rules will come into effect 12 months after the expiration of the retention period of their existing license or the final publication of the amendments. The rules will be implemented based on the later of the two dates.






